Statins for Secondary Prevention of Cardiovascular Disease: The Right Dose

Publisher： Karger

E-ISSN： 1423-0313|87|1-2|63-69

ISSN： 0031-7012

Source： Pharmacology, Vol.87, Iss.1-2, 2011-01, pp. : 63-69

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Do the Effects of Secondary Prevention of Cardiovascular Events in PAD Patients Differ from Other Atherosclerotic Disease?

By Poredos Pavel Jezovnik Mateja Kaja

International Journal of Molecular Sciences, Vol. 16, Iss. 7, 2015-06 ,pp. : 14477-14489

MDPI

Access to resources Recommend Favorite

Nutritional Recommendations for Cardiovascular Disease Prevention

By Eilat-Adar Sigal Sinai Tali Yosefy Chaim Henkin Yaakov

Nutrients, Vol. 5, Iss. 9, 2013-09 ,pp. : 3646-3683

MDPI

Access to resources Recommend Favorite

Nattokinase: An Oral Antithrombotic Agent for the Prevention of Cardiovascular Disease

By Weng Yunqi Yao Jian Sparks Sawyer Wang Kevin Yueju

International Journal of Molecular Sciences, Vol. 18, Iss. 3, 2017-02 ,pp. : 523-523

MDPI

Access to resources Recommend Favorite

Treatment Strategy for Dyslipidemia in Cardiovascular Disease Prevention: Focus on Old and New Drugs

By Zodda Donatella Giammona Rosario Schifilliti Silvia

Pharmacy, Vol. 6, Iss. 1, 2018-01 ,pp. : 10-10

MDPI

Access to resources Recommend Favorite

Chlamydia pneumoniae and Oxidative Stress in Cardiovascular Disease: State of the Art and Prevention Strategies

By Di Pietro Marisa Filardo Simone De Santis Fiorenzo Mastromarino Paola Sessa Rosa

International Journal of Molecular Sciences, Vol. 16, Iss. 1, 2014-12 ,pp. : 724-735

MDPI

Access to resources Recommend Favorite